| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2009 | US20090182002 Tyrosine kinase inhibitors |
| 07/16/2009 | US20090182001 Inhibitors of checkpoint kinases |
| 07/16/2009 | US20090182000 Steroidal compounds as steroid sulphatase inhibitors |
| 07/16/2009 | US20090181999 Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders |
| 07/16/2009 | US20090181998 Opioid receptor subtype-selective agents |
| 07/16/2009 | US20090181997 Therapeutic cancer treatments |
| 07/16/2009 | US20090181996 Substituted quinolones iii |
| 07/16/2009 | US20090181995 2-anilino-4-aminoalkyleneaminopyrimidines |
| 07/16/2009 | US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/16/2009 | US20090181993 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 07/16/2009 | US20090181992 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 07/16/2009 | US20090181991 Compounds and compositions as protein kinase inhibitors |
| 07/16/2009 | US20090181990 Stable amorphous form of pemetrexed disodium |
| 07/16/2009 | US20090181989 Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer |
| 07/16/2009 | US20090181988 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof |
| 07/16/2009 | US20090181987 Inhibitors of brutons tyrosine kinase |
| 07/16/2009 | US20090181986 Substituted heterocyclic compounds |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181984 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 07/16/2009 | US20090181983 Six-membered heterocycles useful as serine protease inhibitors |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181981 Crystalline (r)-2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 07/16/2009 | US20090181979 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 07/16/2009 | US20090181978 5-ht1a receptor subtype agonist |
| 07/16/2009 | US20090181977 Anhydrous Amorphous Imatinib Mesylate |
| 07/16/2009 | US20090181976 Use of Compounds Binding to the Sigma Receptor for the Treatment of Metabolic Syndrome |
| 07/16/2009 | US20090181975 Nebivolol in the treatment of sexual dysfunction |
| 07/16/2009 | US20090181974 Composition for slowing down the development of alzheimer's disease |
| 07/16/2009 | US20090181973 Medicinal composition comprising 3-alkoxy-6-allylthiopyridazines for prevention or treatment of cancer of the pancreas |
| 07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181970 Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
| 07/16/2009 | US20090181969 Hypotensive Lipid And Timolol Compositions And Methods Of Using Same |
| 07/16/2009 | US20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides |
| 07/16/2009 | US20090181967 New compounds I |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181965 Modulators for amyloid beta |
| 07/16/2009 | US20090181964 Propane-1,3-Dione Derivative or Salt Thereof |
| 07/16/2009 | US20090181963 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/16/2009 | US20090181961 Novel medicaments for the treatment of respiratory diseases |
| 07/16/2009 | US20090181960 17BetaHSD TYPE 5 INHIBITOR |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181957 Benzimidazolone derivatives as cb2 receptor ligands |
| 07/16/2009 | US20090181955 Antibacterial Agents |
| 07/16/2009 | US20090181954 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 07/16/2009 | US20090181953 Compound forms and uses thereof |
| 07/16/2009 | US20090181952 Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
| 07/16/2009 | US20090181951 Parp inhibitors |
| 07/16/2009 | US20090181950 Histamine Receptor Antagonists Comprising an Azepin Core |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181948 Diamine derivative |
| 07/16/2009 | US20090181946 Benzaepinones as Sodium Channel Blockers |
| 07/16/2009 | US20090181945 Two cyclic cinnamide compound |
| 07/16/2009 | US20090181944 Method for cancer therapy |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181942 Tricyclic compounds |
| 07/16/2009 | US20090181941 Pyrrolopyrimidines and Pyrrolopyridines |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/16/2009 | US20090181939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders |
| 07/16/2009 | US20090181938 Aminopyrimidines useful as kinase inhibitors |
| 07/16/2009 | US20090181937 Cross-linked fatty acid-based biomaterials |
| 07/16/2009 | US20090181936 antiandrogen compounds, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in the prevention and treatment of conditions mediated by androgen receptors, such as prostrate cancer |
| 07/16/2009 | US20090181935 Compositions comprising an antimuscarinic and a long-acting beta-agonist |
| 07/16/2009 | US20090181934 Organic Compounds |
| 07/16/2009 | US20090181933 Use of steroids to treat persons suffering from ocular disorders |
| 07/16/2009 | US20090181932 COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS |
| 07/16/2009 | US20090181931 Antiviral activity of cidofovir against oncolytic viruses |
| 07/16/2009 | US20090181930 Kinase inhibitory phosphonate analogs |
| 07/16/2009 | US20090181929 Organic compounds |
| 07/16/2009 | US20090181928 Organic compounds |
| 07/16/2009 | US20090181927 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 07/16/2009 | US20090181925 Compositions for treating and preventing hyperlipidemia |
| 07/16/2009 | US20090181924 Compositions Comprising Glycosaminoglycans of Low Viscosity and Use of Said Composition in Therapy of Chronic Cystitis |
| 07/16/2009 | US20090181923 Method of increasing weight gain and reducing diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics |
| 07/16/2009 | US20090181922 Palatinose for enhancing dietary supplement and pharmaceutical delivery |
| 07/16/2009 | US20090181921 2-5a analogs and their methods of use |
| 07/16/2009 | US20090181920 Intrathecal treatment of neuropathic pain with a2ar agonists |
| 07/16/2009 | US20090181919 Method for Freeze-Drying Nucleic Acid/Block Copolymer/Cationic Surfactant Complexes |
| 07/16/2009 | US20090181917 Men1 gene for diagnosis and treatment of diabetes |
| 07/16/2009 | US20090181916 Lna antagonists targeting the androgen receptor |
| 07/16/2009 | US20090181915 Transcription factor arntl2 gene and expression products thereof used in the diagnosis, prevention, and treatment of type 1 diabetes |
| 07/16/2009 | US20090181914 Lna oligonucleotides and the treatment of cancer |
| 07/16/2009 | US20090181913 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
| 07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 07/16/2009 | US20090181911 Role of gax in alzheimer neurovascular dysfunction |
| 07/16/2009 | US20090181910 Method of prevention and alleviation of toxicity by modulation of irf3 |
| 07/16/2009 | US20090181908 Methods and compositions for treating keratin hyperproliferative disorders |
| 07/16/2009 | US20090181907 Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter |
| 07/16/2009 | US20090181906 Combination Therapies using Melengestrol Acetate and Zilpaterol or its Salts |
| 07/16/2009 | US20090181905 Crystalline form of 1' -(1-methylethyl)-4' -[(2-fluoro-4-methoxyphenyl)methyl]-5' -methyl-1h-pyrazol-3' -o-beta-d-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
| 07/16/2009 | US20090181904 Method for regulating nutrient absorption with ginsenosides |
| 07/16/2009 | US20090181903 An amino acid component including > 11 percent by mass leucine and an amino acid(s) from the group of histidine, isoleucine, valine, lysine, methionine, phenylalanine, threonine, arginine, glycine, carnitine, and citrullene; also a carbohydrate and creatine; stimulating muscle protein synthesis |
| 07/16/2009 | US20090181902 Modulators of pharmacokinetic properties of therapeutics |
| 07/16/2009 | US20090181901 Compositions and methods to increase bioavailability of carotenoids |
| 07/16/2009 | US20090181900 Novel peptides and methods for the treatment of inflammatory disease |
| 07/16/2009 | US20090181898 Abuse-resistant amphetamine prodrugs |
| 07/16/2009 | US20090181896 Use of Natriuretic Peptide Receptor Antagonists to Treat Ocular, Otic and Nasal Edemetous Conditions |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |